Zanco Journal of Medical Sciences
 
Skip Navigation Links
Home
Available Issues
Search
Editorial Board
Information for Authors
Review Process
Copyright
Links and Contacts
  Zanko J Med Sci:  Aug. 2017; 21 (2): 1765-1771

MRI findings in primary brain lymphoma in immunocompetent patients

Saeed Nadhim Younis*, Aras Rafeiq Abdullah*

 
* Department of Surgery, College of Medicine, Hawler Medical University, Erbil, Iraq.
 


Abstract

Background and objective: Primary brain lymphoma is an extranodal aggressive intracranial neoplasm of lymphocytic origin originating and confined to the brain parenchyma and meninges. It is rare in immune competent patients, but its incidence is increasing. This retrospective study was conducted to record the MRI features of primary brain lymphoma at the time of diagnosis in immunocompetent patients.

Methods: Of the 450 patients diagnosed with the brain tumor during a period of five years from 2008 to 2013, the clinical features and MRI findings of 16 cases of pathologically proven to be non-Hodgkin’s lymphoma were studied. All the patients were tested negative for HIV and there was no history of immune suppression drugs or any other chronic illness. All the patients were examined with MRI observing the tumor location, multifocality, signal intensity in different sequences, enhancement patterns, peritumoral edema, the presence of hemorrhage and calcification.

Results: Of the 16 patients, including the monofocal and multifocal cases, 30 lesions exhibited. The mean age at diagnosis was 53 years. Nine patients (56.25%) found to have a multifocal disease. In more than 75% of lesions, MRI was hypo to iso signal on T1 and T2. Mild to moderate perilesional edema, strong contrast enhancement and restricted diffusion were seen in all cases. The hemorrhagic tumor was noticed in four lesions (13.3%). No calcification and no leptomeningeal lesions were noted. The MRI images in post steroid therapy were studied within one month of treatment. Tumour regression was noticed in 21/30 (70%), stable in 3/30 (10%) and progressing in 6/30 (20%). 

Conclusion: MRI is a reliable imaging technique in the management of patients with primary brain lymphoma. Early accurate diagnosis is crucial to avoid the unnecessary operation and shift patients from extensive surgery to chemoradiotherapy.

Keywords: MRI; Brain Lymphoma; immune competent; Tumor regression



Reference

1. De Belder F, Van Cauter S, van den Hauwe L, Van Hecke W, Emsell L, De Belder M, et al. DTI in diagnosis and follow-up of brain tumours. In: Diffusion Tensor Imaging. New York: Springer; 2016. Available at http.springer.com/chapter/10.1007%2F978-1-4939-3118-7-15,2016

2. Shenkier TN, Blay JY, O’Neill BP, Poortmans P, Thiel E, Jahnke K, et al. Primary CNS lymphoma of T-cell origin: A descriptive analysis from the international primary CNS lymphoma collaborative group. J Clin Oncol 2005; 23: 2233–9.

3. Olson JE, Janney CA, Rao RD, Cerhan JR, Kurtin PJ, Schiff D, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 2002; 95: 1504–10.

4. Haldorsen IS, Espeland A, Larsson EM, Central nervous system lymphoma: characteristic findings on traditional and advanced imaging, AJNR 2011:32:984-92.

5. Barajas RF, Rubenstein JL, Chang JS. Diffusion weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. AJNR 2010; 31: 60-6.

6. Coulon A, Lafitte F, Hoang-Xuan K, Martin-Duverneuil N, Mokhtari K, Blustajn J, et al. Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients. Eur 2002; 12:329-40.

7. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. J Nat Cancer Inst 2002; 92(3):205-16.

8. Zhang D, Hu LB, Henning TD, Ravarani EM, Zou LG, Feng XY, et al. MRI findings of primary CNS lymphoma in 26 Immunocompetent patients. KJR 2010; 11(3):269-77.

9. Alaa EL, Iman Z. primary central nervous system lymphoma: incorporating MRI in the planning of treatment strategies. J Egyptian Nat Cancer Inst 2001; 13 (3): 237-44.

10. Russel DS, Rubinstein LJ, pathology of tumors of nervous system. 5th ed. Baltimore: Williams and Wilkins; 1989.

11. Buhring U, Herrlinger U. MRI features of primary central nervous system lymphoma at presentation. Neurology 2001; 57 (3): 393-6.

12. Jack CR, O’Neil BP, Banks PM, Rse DF: central nervous system lymphoma: histological types and CT appearance. Radiology1988; 167:211-5.

13. Osborn AG. Diagnostic neuroradiology. St. Louis, MO: Mosby; 1994.

14. Rumana M, Khursheed N, Ahmad R, Altaf K, Altaf R ,Muhammad B K, et al. Primary CNS Lymphoma in Immunocompetent: A Review of Literature and Our Experience from Kashmir. Turkish Neurosurgery 2011; 21(1): 39-47.

15. Partovi S, Karimi S, Lyo JK, EsmaeiliA, TAN J, Deangelis LM. Multimodality imaging of primary CNS lymphoma in immunocompetent patients. Br J Radiol 2014; 87(1036): 20130684.

16. Horger M, Fenchel M, Nagele T, Moehle R, Claussen CD, Beschorner R, et al. Water diffusivity: comparison of primary CNS lymphoma and astrocytic tumor infiltrating the corpus callosum. AJR 2009; 193: 1384–7.



Slightly know the replica watches uk fashionable women, even if you do not understand the replica watches also know that Cartier tanks, after all, this is the rolex replica royal family, film stars, literary celebrities, and rolex replica uk even political places are wearing watches.